Zhanjun Jia

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Topics

Acute Kidney Injury

Top Venues

EMBO molecular medicine

Journal of clinical medicine

Clinical science (London, England : 1979)

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Gong, Lingling Lu, Haoyang Ma, Mingfeng Shan, Xinwen Fan, Mi Bai, Yue Zhang, Songming Huang, Zhanjun Jia, Aihua Zhang
DY131 activates ERRγ/TFAM axis to protect against metabolic disorders and acute kidney injury. Clinical science (London, England : 1979) 138 (13) (2024)
Wei Gong, Lingling Lu, Haoyang Ma, Mingfeng Shan, Xinwen Fan, Mi Bai, Yue Zhang, Songming Huang, Zhanjun Jia, Aihua Zhang
DY131 activates ERRγ/TFAM axis to protect against metabolic disorders and acute kidney injury. Clinical science (London, England : 1979) 138 (13) (2024)
Ran You, Zhanjun Jia
Pathophysiological role of Na-Cl cotransporter in kidneys, blood pressure, and metabolism. Human cell 37 (5) (2024)
Ran You, Zhanjun Jia
Pathophysiological role of Na-Cl cotransporter in kidneys, blood pressure, and metabolism. Human cell 37 (5) (2024)
Ran You, Zhanjun Jia
Pathophysiological role of Na-Cl cotransporter in kidneys, blood pressure, and metabolism. Human cell (2024)
Yang Du, Yaqiong Shang, Yun Qian, Yan Guo, Shuang Chen, Xiuli Lin, Weidong Cao, Xiaomei Tang, Anning Zhou, Songming Huang, Aihua Zhang, Zhanjun Jia, Yue Zhang
Plk1 promotes renal tubulointerstitial fibrosis by targeting autophagy/lysosome axis. Cell death & disease 14 (8) (2023)
Huixia Li, Chunli Wang, Ruochen Che, Aihua Zhang, Wei Zhou, Songming Huang, Zhanjun Jia, Aihua Zhang, Fei Zhao, Guixia Ding
A Potential Therapy Using Antisense Oligonucleotides to Treat Autosomal Recessive Polycystic Kidney Disease. Journal of clinical medicine 12 (4) (2023)
Lingling Lu, Weihua Liu, Shumin Li, Mi Bai, Yu Zhou, Zhaohui Jiang, Zhanjun Jia, Songming Huang, Aihua Zhang, Wei Gong
Flavonoid derivative DMXAA attenuates cisplatin-induced acute kidney injury independent of STING signaling. Clinical science (London, England : 1979) 137 (6) (2023)
Huixia Li, Chunli Wang, Ruochen Che, Aihua Zhang, Wei Zhou, Songming Huang, Zhanjun Jia, Aihua Zhang, Fei Zhao, Guixia Ding
A Potential Therapy Using Antisense Oligonucleotides to Treat Autosomal Recessive Polycystic Kidney Disease. Journal of clinical medicine 12 (4) (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Mengqiu Wu, Qianqian Jin, Xinyue Xu, Jiaojiao Fan, Weiyi Chen, Mengqiu Miao, Ran Gu, Shengnan Zhang, Yan Guo, Songming Huang, Yue Zhang, Aihua Zhang, Zhanjun Jia
TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Shihan Cao, Qian Wang, Zhenzhen Sun, Yue Zhang, Qianqi Liu, Qun Huang, Guixia Ding, Zhanjun Jia
Role of cuproptosis in understanding diseases. Human cell (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Yunwen Yang, Suwen Liu, Peipei Wang, Jing Ouyang, Ning Zhou, Yue Zhang, Songming Huang, Zhanjun Jia, Aihua Zhang
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives chronic kidney disease progression in male mice. Nature communications 14 (1) (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Dandan Zhong, Lingling Quan, Chang Hao, Jingshuo Chen, Ranran Qiao, Tengfei Lin, Changjiang Ying, Dong Sun, Zhanjun Jia, Ying Sun
Targeting mPGES-2 to protect against acute kidney injury via inhibition of ferroptosis dependent on p53. Cell death & disease 14 (10) (2023)
Huixia Li, Chunli Wang, Ruochen Che, Aihua Zhang, Wei Zhou, Songming Huang, Zhanjun Jia, Aihua Zhang, Fei Zhao, Guixia Ding
A Potential Therapy Using Antisense Oligonucleotides to Treat Autosomal Recessive Polycystic Kidney Disease. Journal of clinical medicine 12 (4) (2023)
Shihan Cao, Qian Wang, Zhenzhen Sun, Yue Zhang, Qianqi Liu, Qun Huang, Guixia Ding, Zhanjun Jia
Role of cuproptosis in understanding diseases. Human cell (2023)
Yunwen Yang, Suwen Liu, Peipei Wang, Jing Ouyang, Ning Zhou, Yue Zhang, Songming Huang, Zhanjun Jia, Aihua Zhang
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives chronic kidney disease progression in male mice. Nature communications 14 (1) (2023)
Huixia Li, Chunli Wang, Ruochen Che, Aihua Zhang, Wei Zhou, Songming Huang, Zhanjun Jia, Aihua Zhang, Fei Zhao, Guixia Ding
A Potential Therapy Using Antisense Oligonucleotides to Treat Autosomal Recessive Polycystic Kidney Disease. Journal of clinical medicine 12 (4) (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Yunwen Yang, Suwen Liu, Peipei Wang, Jing Ouyang, Ning Zhou, Yue Zhang, Songming Huang, Zhanjun Jia, Aihua Zhang
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives chronic kidney disease progression in male mice. Nature communications 14 (1) (2023)
Dandan Zhong, Zhikang Wan, Jie Cai, Lingling Quan, Rumeng Zhang, Tian Teng, Hang Gao, Chenyu Fan, Meng Wang, Dong Guo, Hongxing Zhang, Zhanjun Jia, Ying Sun
mPGES-2 blockade antagonizes β-cell senescence to ameliorate diabetes by acting on NR4A1. Nature metabolism 4 (2) (2022)
Yunwen Yang, Fangfang Cai, Ning Zhou, Suwen Liu, Peipei Wang, Shengnan Zhang, Yue Zhang, Aihua Zhang, Zhanjun Jia, Songming Huang
Dimethyl fumarate prevents ferroptosis to attenuate acute kidney injury by acting on NRF2. Clinical and translational medicine 11 (4) (2022)
Xiao-Wen Yu, Man Xu, Xia Meng, Shumin Li, Qian-Qi Liu, Mi Bai, Ran You, Songming Huang, Li Yang, Yue Zhang, Zhanjun Jia, Aihua Zhang
Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI. Science translational medicine 12 (543) (2021)
Weiwei Xia, Yuanyuan Li, Mengying Wu, Qianqian Jin, Qian Wang, Shuzhen Li, Songming Huang, Aihua Zhang, Yue Zhang, Zhanjun Jia
Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation. Cell death & disease 12 (2) (2021)
Wei Gong, Lingling Lu, Yu Zhou, Jiaye Liu, Haoyang Ma, Lvhan Fu, Songming Huang, Yue Zhang, Aihua Zhang, Zhanjun Jia
The novel STING antagonist H151 ameliorates cisplatin-induced acute kidney injury and mitochondrial dysfunction. American journal of physiology. Renal physiology 320 (4) (2021)
Mengqiu Wu, Weiyi Chen, Mengqiu Miao, Qianqian Jin, Shengnan Zhang, Mi Bai, Jiaojiao Fan, Yue Zhang, Aihua Zhang, Zhanjun Jia, Songming Huang
Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability. Clinical science (London, England : 1979) 135 (14) (2021)
Xiao-Wen Yu, Yue Zhang, Zhanjun Jia, Aihua Zhang
Response to comment on "Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI". Science translational medicine 13 (593) (2021)
Weiwei Xia, Yuanyuan Li, Mengying Wu, Jie Yin, Yue Zhang, Hongbing Chen, Songming Huang, Zhanjun Jia, Aihua Zhang
Inhibition of mitochondrial activity ameliorates atherosclerosis in ApoE-/- mice via suppressing vascular smooth cell activation and macrophage foam cell formation. Journal of cellular biochemistry 120 (10) (2019)